New Age Alpha Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Sell
1,242
-51
-4% -$7.57K 0.01% 736
2026
Q1
$120K Sell
1,293
-29
-2% -$2.57K 0.01% 675
2025
Q4
$106K Buy
1,322
+380
+40% +$31.8K ﹤0.01% 677
2025
Q3
$92K Sell
942
-13
-1% -$1.05K ﹤0.01% 726
2025
Q2
$66.6K Sell
955
-26
-3% -$1.48K ﹤0.01% 757
2025
Q1
$48.7K Sell
981
-890
-48% -$56.3K ﹤0.01% 817
2024
Q4
$131K Buy
+1,871
New +$155K 0.01% 719

Other funds holding ACLS

New Age Alpha Advisors's ACLS Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Axcelis (ACLS) stake by 3.9% in Q2 2026, selling an estimated $7.57K and leaving 1,242 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #736.

New Age Alpha Advisors first reported a position in ACLS in Q4 2024 and has held it in 7 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • New Age Alpha Advisors held 1,242 shares of Axcelis worth $235K as of Q2 2026.
  • New Age Alpha Advisors sold 51 Axcelis shares in Q2 2026, an estimated $7.57K.
  • Axcelis made up 0.01% of New Age Alpha Advisors's portfolio in Q2 2026, its #736 holding.
  • New Age Alpha Advisors first reported a position in Axcelis in Q4 2024 and has held it in 7 quarters since.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.